Muscular Dystrophy Association 2019 Clinical and Scientific Conference

Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Orlando, FL on April 14- April 16. She presented two posters:

• Development of a Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Consortium
• Value of Skeletal Muscle Damage Biomarkers as Pharmacodynamic Biomarkers for Neuromuscular Diseases.